Antibodies News and Research

RSS

Study finds potential treatment for patients with Complex Regional Pain Syndrome

A study, published today in PNAS, has found a potential treatment for patients with Complex Regional Pain Syndrome.

11 Jun 2019

Novel agent shown to have dual mechanism of action to eliminate cancer

Results from a study spearhead by researchers at the Vall d´Hebron Institute of Oncology (VHIO), show that the blockade of the multi-functional cytokine LIF induces tumor-infiltrating T Cells to hone in on and eliminate cancer.

11 Jun 2019

Complex molecular conversation is key to the establishment of 'hot tumor'

A Ludwig Cancer Research study has deciphered a complex molecular conversation between cancer and immune cells that is key to orchestrating the successful invasion of tumors by T cells that kill cancer cells.

11 Jun 2019

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet's Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

10 Jun 2019

EAF2000 advances complex charged molecule studies

Postnova Analytics reports on growing use of its pioneering EAF2000 system to separate and characterize complex proteins, antibodies and viruses as well as charged nanoparticles, colloids and polymers.

From Postnova Analytics 10 Jun 2019

Scientists 'on the right track' toward universal flu vaccine

New research could bring scientists a step closer to developing an effective, universal flu vaccine.

4 Jun 2019

Snapshot of chikungunya could help find new ways to prevent or treat viral arthritis

Chikungunya virus, once confined to the Eastern Hemisphere, has infected more than 1 million people in the Americas since 2013, when mosquitoes carrying the virus were discovered in the Caribbean.

4 Jun 2019

Study reveals novel indicator of protection against influenza virus infection

A study of influenza virus transmission in Nicaraguan households reveals new insights into the type of immune responses that may be protective against influenza virus infection, report investigators.

4 Jun 2019

Texas Biomed awarded $2 million DOD grant to study promising Zika vaccine

The emerging Zika virus is a particular threat to pregnant women. The disease can be transmitted by the bite of an infected mosquito and is associated with devastating birth defects, like microcephaly. No approved vaccine against the virus exists.

3 Jun 2019

Powerful separation technique opens door to characterizing complex samples

From Postnova Analytics 31 May 2019

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

A team of researchers from Indiana University and Memorial Sloan Kettering Cancer Center have been awarded a $4.1 million National Cancer Institute "Cancer Moonshot" grant to develop immunotherapy treatments for cancer in children and adolescents, especially those with leukemia.

31 May 2019

Mothers can transfer life-long protection against infection to infants by breastfeeding

Mothers can transfer life-long protection against infection to their infants by breastfeeding. This was the finding from new research in mice by an international team of scientists led by researchers at the University of Cape Town.

31 May 2019

Study: Mothers' breast milk can provide protection against infection that lasts for life

Mothers' breast milk can provide protection against infection that lasts for life, finds new research in mice by an international team of scientists including experts at the University of Birmingham.

30 May 2019

New fluorescent probe specifically labels microglia cells

Part of the immune system in the brain is made up of so-called microglia cells. Korean and Singaporean researchers have now developed a fluorescent probe that specifically labels this type of macrophage. The cells were visualized in cell culture and in the live brains of rodents.

29 May 2019

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

A decade ago researchers announced development of a cancer immunotherapy called CAR (for chimeric antigen receptor)-T, in which a patient is re-infused with their own genetically modified T cells equipped to mount a potent anti-tumor attack.

28 May 2019

Cancer stem cells adapt to environmental conditions and undergo reversible transformations

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed, hierarchical order.

25 May 2019

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

25 May 2019

Overexpression of tumor suppressor gene may lead to B-cell lymphoma, study finds

Miguel Gallardo, researcher and coordinator of the H12O-CNIO Haematological Malignancies Clinical Research Unit headed by Joaquín Martínez at the Spanish National Cancer Research Centre, has participated in a study that revealed that hnRNP K overexpression may cause B-cell lymphomas, the most common types of blood cancer.

24 May 2019

Study sheds light on the burden of dengue in Bangladesh

Dengue, also known as dengue fever, is a viral disease transmitted to humans by mosquitoes of the genus Aedes.

24 May 2019

NIAID announces two awards for the study of influenza immunity in kids

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has announced two awards for the study of influenza immunity in children.

23 May 2019

Antibodies News and Research

Study finds potential treatment for patients with Complex Regional Pain Syndrome

Novel agent shown to have dual mechanism of action to eliminate cancer

Complex molecular conversation is key to the establishment of 'hot tumor'

Drug that targets the immune system can delay type 1 diabetes in high risk children, adults

EAF2000 advances complex charged molecule studies

Scientists 'on the right track' toward universal flu vaccine

Snapshot of chikungunya could help find new ways to prevent or treat viral arthritis

Study reveals novel indicator of protection against influenza virus infection

Texas Biomed awarded $2 million DOD grant to study promising Zika vaccine

Powerful separation technique opens door to characterizing complex samples

IU researchers, collaborators receive grant to develop immunotherapy treatments for cancer

Mothers can transfer life-long protection against infection to infants by breastfeeding

Study: Mothers' breast milk can provide protection against infection that lasts for life

New fluorescent probe specifically labels microglia cells

Genetically eliminating TOX factors improves eradication of solid tumors in CAR T model

Cancer stem cells adapt to environmental conditions and undergo reversible transformations

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

Overexpression of tumor suppressor gene may lead to B-cell lymphoma, study finds

Study sheds light on the burden of dengue in Bangladesh

NIAID announces two awards for the study of influenza immunity in kids

Antibodies eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News